BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25194213)

  • 1. Contemporary analysis of pelvic and para-aortic metastasis in endometrial cancer using the SEER registry.
    Katsoulakis E; Mattes MD; Rineer JM; Nabhani T; Mourad WF; Choi K; Schreiber D
    Int J Gynaecol Obstet; 2014 Dec; 127(3):293-6. PubMed ID: 25194213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of pelvic and para-aortic node metastases in early-stage ovarian cancer.
    Bachmann C; Krämer B; Brucker SY; Stäbler A; Fend F; Wallwiener D; Grischke EM; Rothmund R
    Anticancer Res; 2014 Nov; 34(11):6735-8. PubMed ID: 25368283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of nodal metastasis and isolated aortic metastases in patients with surgically staged endometrioid endometrial cancer.
    Sautua RR; Goiri K; Calle MA; Marin IJ; Artola AL
    Int J Gynecol Cancer; 2015 Jun; 25(5):875-8. PubMed ID: 25774712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer.
    Solmaz U; Mat E; Dereli ML; Turan V; Tosun G; Dogan A; Sanci M; Ozdemir IA; Pala EE
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():63-7. PubMed ID: 25638600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy.
    Sueoka K; Umayahara K; Abe A; Usami T; Yamamoto A; Nomura H; Matoda M; Okamoto S; Omatsu K; Kondo E; Kato K; Takeshima N
    Int J Gynecol Cancer; 2015 Jan; 25(1):81-6. PubMed ID: 25347094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry.
    Mattes MD; Lee JC; Metzger DJ; Ashamalla H; Katsoulakis E
    J Gynecol Oncol; 2015 Jan; 26(1):19-24. PubMed ID: 25310855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucinous Adenocarcinoma of the Endometrium Compared With Endometrioid Endometrial Cancer: A SEER Analysis.
    Rauh-Hain JA; Vargas RJ; Clemmer J; Clark RM; Bradford LS; Growdon WB; Goodman A; Boruta DM; Schorge JO; del Carmen MG
    Am J Clin Oncol; 2016 Feb; 39(1):43-8. PubMed ID: 24390270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Metastatic Regional Lymph Node Locations and Predictors of Para-aortic Lymph Node Involvement in Endometrial Cancer Patients at Risk for Lymphatic Dissemination.
    Altay A; Toptas T; Dogan S; Simsek T; Pestereli E
    Int J Gynecol Cancer; 2015 May; 25(4):657-64. PubMed ID: 25647255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prediction of para-aortic lymph node metastasis in endometrioid adenocarcinoma of endometrium.
    Numanoglu C; Corbacioglu Esmer A; Ulker V; Goksedef BP; Han A; Akbayir O; Guraslan B
    J Obstet Gynaecol; 2014 Feb; 34(2):177-81. PubMed ID: 24456443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pelvic and para-aortic lymphadenectomy for surgical staging of high-risk endometrioid adenocarcinoma of the endometrium.
    Larson DM; Johnson KK
    Gynecol Oncol; 1993 Dec; 51(3):345-8. PubMed ID: 8112643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should all endometrioid uterine cancer patients undergo systemic lymphadenectomy?
    Wang ZQ; Wang JL; Shen DH; Li XP; Wei LH
    Eur J Surg Oncol; 2013 Apr; 39(4):344-9. PubMed ID: 23333067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pelvic and para-aortic lymphadenectomy in patients with endometrioid adenocarcinoma of the endometrium.
    Geisler JP; Linnemeier GC; Manahan KJ
    Int J Gynaecol Obstet; 2007 Jul; 98(1):39-43. PubMed ID: 17490668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-specific factors for cancer of the corpus uteri from SEER registries: collaborative stage data collection system, version 1 and version 2.
    Jamison PM; Altekruse SF; Chang JT; Zahn J; Lee R; Noone AM; Barroilhet L
    Cancer; 2014 Dec; 120 Suppl 23():3836-45. PubMed ID: 25412395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of lymph node metastasis sites in endometrial cancer undergoing systematic pelvic and para-aortic lymphadenectomy: a proposal of optimal lymphadenectomy for future clinical trials.
    Odagiri T; Watari H; Kato T; Mitamura T; Hosaka M; Sudo S; Takeda M; Kobayashi N; Dong P; Todo Y; Kudo M; Sakuragi N
    Ann Surg Oncol; 2014 Aug; 21(8):2755-61. PubMed ID: 24705578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrastaging of para-aortic lymph nodes in stage IIIC1 endometrial cancer: a preliminary report.
    Todo Y; Suzuki Y; Azuma M; Hatanaka Y; Konno Y; Watari H; Kato H; Matsuno Y; Yamashiro K; Sakuragi N
    Gynecol Oncol; 2012 Dec; 127(3):532-7. PubMed ID: 22940490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical analysis on the lymph nodes metastasis characters and their relation with the prognosis of the endometrial carcinoma patients].
    Wang ZQ; Zhang Y; Wang JL; Shen DH; Zhao X; Yao YY; Bai Y; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jun; 46(6):435-40. PubMed ID: 21781585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysis.
    Vargas R; Rauh-Hain JA; Clemmer J; Clark RM; Goodman A; Growdon WB; Schorge JO; Del Carmen MG; Horowitz NS; Boruta DM
    Gynecol Oncol; 2014 May; 133(2):216-20. PubMed ID: 24548726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological study on para-aortic lymph node metastasis without pelvic lymph node metastasis in endometrial cancer.
    Tomisato S; Yamagami W; Susumu N; Kuwahata M; Takigawa A; Nomura H; Kataoka F; Hirasawa A; Banno K; Aoki D
    J Obstet Gynaecol Res; 2014 Jun; 40(6):1733-9. PubMed ID: 24888941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of gross myometrial invasion with endometrial cancer.
    Larson DM; Connor GP; Broste SK; Krawisz BR; Johnson KK
    Obstet Gynecol; 1996 Sep; 88(3):394-8. PubMed ID: 8752246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.